The US endotracheal tubes market demonstrates sustained growth, starting at 750 Million USD in 2020 and reaching approximately 1,195 Million USD by 2025. This upward trajectory is propelled by technological innovations, broader healthcare access, and a higher prevalence of respiratory conditions. The market is projected to approach 2,015 Million USD by 2035, representing a swift compound annual growth rate. Notably, demand from tertiary care hospitals and emergency departments remains consistently strong, while outpatient and ambulatory care settings are emerging as secondary growth drivers.
Read More - https://bussinessinsights.com/research-report/us-endotracheal-tubes
Emergency treatment represents the largest application for endotracheal tubes in the US in 2025, reflecting the growing incidence of acute respiratory events, trauma cases, and critical care admissions. Surgery is another major segment, as intubation remains mandatory for most operative procedures under general anesthesia. Airway management—including ICU and chronic care—holds a substantial share, while therapy-related uses cater to both acute and chronic respiratory conditions. The ‘Others’ category includes research, ambulatory care, and field applications, which, although smaller, continue to grow with new use-cases.
Request Free Sample- https://bussinessinsights.com/request/medical-devices/us-endotracheal-tubes
Who are the key players in US Endotracheal Tubes industry?
Key players include Medtronic, Teleflex, Smiths Medical, Becton Dickinson (BD), and Armstrong Medical. These companies dominate the market due to their innovation, extensive product portfolios, and strong distribution networks. Medtronic and Teleflex, in particular, are noted for their advanced airway management solutions and technological advancements.
What is the US Endotracheal Tubes growth?
The US endotracheal tubes market has been experiencing steady growth, driven by increasing surgical procedures and critical care admissions. For instance, Becton Dickinson reported significant growth in its respiratory care segment in 2023, propelled by rising demand for advanced airway management devices.
Which segment accounted for the largest US Endotracheal Tubes share?
The largest share belongs to the hospital end-use segment, due to the high volume of intubations performed during surgeries and emergency care. The growing number of hospital-based surgical and intensive care procedures has made hospitals the leading application area for endotracheal tubes.
Thanks & Regards,
Manisha C
sales [at] bussinessinsights.com